Breaking News
July 17, 2018 - Researchers map family trees of cancer cells to understand how AML responds to new drug
July 17, 2018 - Mortality from heart failure remains higher in women than men
July 17, 2018 - Can-Fite BioPharma receives Australian and Chinese patents for new drug to treat erectile dysfunction
July 17, 2018 - AAP: Lawnmowers Pose Serious Injury Risk to Children
July 17, 2018 - Fewer U.S. kids are getting cavities
July 17, 2018 - Differences in brain’s reward circuit may explain social deficits in autism
July 17, 2018 - YCC researchers suggest promising treatment for two rare inherited cancer syndromes
July 17, 2018 - FAU and partners receive NIH research grant to shed light on sleep loss and metabolic disorders
July 17, 2018 - Advanced MRI technique predicts risk of disease progression in MS
July 17, 2018 - Health Tip: Microwave Safely – Drugs.com MedNews
July 17, 2018 - New target for treating heart failure identified
July 17, 2018 - Biodesign fellows simplify heart rhythm monitoring
July 17, 2018 - Study reveals new risk genes for allergic rhinitis
July 17, 2018 - Community college education can increase physician diversity and access to primary care
July 17, 2018 - Inflection Biosciences’ dual mechanism inhibitor shows promise as treatment for CLL
July 17, 2018 - Researchers uncover how cells invite corrupted proteins inside
July 17, 2018 - Studies show HORIBA’s new hematology analyzer improves POCT and care of oncology patients
July 17, 2018 - New website aims to make yoga safer for everyone
July 17, 2018 - Long-term survival worse for black survivors of in-hospital cardiac arrest
July 17, 2018 - Stanford data analyst’s childhood inspires his research: A Q&A
July 17, 2018 - Preventability of hospital readmissions changes over time, study reveals
July 17, 2018 - Nursing notes can help predict if ICU patients will survive
July 17, 2018 - Okayama University research could improve prognosis of diabetic kidney disease
July 17, 2018 - Researchers develop machine learning method to predict unknown gene functions of microbes
July 17, 2018 - Homogenous BTK occupancy assay used in tirabrutinib clinical studies
July 17, 2018 - Study identifies new genes linked to heart function and development
July 17, 2018 - NeuroTrauma Sciences and Henry Ford join hands to advance exosome technology
July 17, 2018 - Improved methods to measure enterococci concentrations in recreational water
July 17, 2018 - White adolescent boys experiencing early puberty have high risk for substance use
July 17, 2018 - Celgene and Acceleron Announce Luspatercept Achieved Primary and All Key Secondary Endpoints in Phase III ‘BELIEVE’ Study in Adults with Transfusion-Dependent Beta-Thalassemia
July 17, 2018 - Roots of leukemia reveal possibility of predicting people at risk
July 17, 2018 - Summer med program embraces low-income students’ potential
July 17, 2018 - New research lays foundation to create standards for RNA sequencing
July 17, 2018 - CRISPR/Cas9 gene editing can cause greater genetic damage than previously thought
July 17, 2018 - Democrats rally against threats to the ACA to block Trump’s Supreme Court nominee
July 17, 2018 - Staggering prices slow insurers’ coverage of CAR-T cancer therapy
July 17, 2018 - How proteins involved in neurodegeneration enter cells
July 17, 2018 - New super-resolution ‘nanoscope’ provides insight into progression of Alzheimer’s disease
July 17, 2018 - FDA Advisory Committee Endorses the Effectiveness and Safety of Single-Dose Tafenoquine for the Radical Cure of P. vivax Malaria
July 17, 2018 - Uncovering the evolutionary history of IBD-associated colorectal cancer
July 17, 2018 - Is nutrition research dependable? Stanford’s John Ioannidis weighs in
July 17, 2018 - New machine learning framework predicts effects of genetic mutations in ‘dark matter’ regions
July 17, 2018 - Plant-based products fail to have positive impact on blood pressure during clinical studies
July 17, 2018 - Electronic system to speed up facial pain diagnosis may improve quality of life and save money
July 17, 2018 - Study delves into the role played by Protein Kinase C in synaptic plasticity
July 17, 2018 - Women Often Unaware of Their Hospital’s Religious Affiliation
July 17, 2018 - New AASM guideline recommends use of actigraphy for sleep disorders
July 17, 2018 - CRISPR editing reduces repetitive behavior in mice with a form of autism
July 17, 2018 - Scientists use magnets to detect cancer
July 17, 2018 - Microfluidic chip to detect sepsis proves successful in clinical study
July 17, 2018 - Research provides better understanding of mechanisms underlying memory storage
July 17, 2018 - A Multi-Modal Approach for the Early Detection of Breast Cancer
July 17, 2018 - Mailing colorectal cancer tests to patients increases screening rates, report researchers
July 17, 2018 - Scientists find possible sources of medicinal and antimicrobial drugs
July 17, 2018 - Molecules formed when the body metabolizes omega-3 fatty acids may inhibit cancer
July 17, 2018 - Efficient communication between hospitals improves patient safety and reduces mortality
July 17, 2018 - Study highlights potential of fetal gene therapy to prevent lethal neurodegenerative disease
July 17, 2018 - For Americans, in Science They Trust
July 17, 2018 - Combating HIV/AIDS | NIH MedlinePlus the Magazine
July 17, 2018 - Study shows minorities widely underrepresented in autism diagnoses
July 17, 2018 - Multigene testing replacing BRCA tests for breast cancer risk | News Center
July 17, 2018 - Pre-clinical pilot study shows promising results of ‘concussion pill’
July 17, 2018 - Researchers reduce size of tumors in mice by artificially activating the brain’s reward system
July 17, 2018 - New study documents symptoms of people before they acquire multiple sclerosis
July 17, 2018 - Researchers discover why CRISPR gene editing sometimes fails
July 17, 2018 - New finding may hold key to better understand the complexities of neurological disorders
July 17, 2018 - The Current issue of “The view from here” is concerned with Novel Targets.
July 17, 2018 - Fighting the Flu with a Universal Vaccine
July 17, 2018 - Key social reward circuit in the brain impaired in kids with autism | News Center
July 17, 2018 - Insight into causes, types and treatment of aphasia
July 16, 2018 - Quark Pharmaceuticals, Inc Announces First Patient Dosed in Phase 3 Clinical Trial of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
July 16, 2018 - NSAIDs shown to have causal role in cardiovascular risk of patients with osteoarthritis
July 16, 2018 - PET scan tracer predicts success of cancer ‘vaccine’ | News Center
July 16, 2018 - Parents struggle with what to do when their child has headache, shows study
July 16, 2018 - Outrageous or overblown? HHS announces another round of ACA navigator funding cuts
July 16, 2018 - Weight loss surgery may impact individual’s risk of developing cancer, shows study
July 16, 2018 - Alexion Submits Application for Priority Review and Approval of ALXN1210 as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) in the U.S.
July 16, 2018 - Restoring epigenetic balance reinstates memory in flies with Alzheimer’s disease symptoms
July 16, 2018 - Magnetized wire could be used to detect cancer in people | News Center
July 16, 2018 - Non-surgical management found to be feasible option for penetrating kidney trauma
Novel CV Risk Marker in RA Identified

Novel CV Risk Marker in RA Identified

image_pdfDownload PDFimage_print

Action Points

  • Anti-citrullinated fibrinogen (anti-cit-fibrinogen) may serve as a potential biomarker for assessing cardiovascular (CV) risk in patients with rheumatoid arthritis (RA).
  • Note that the study suggests that anti-cit-fibrinogens can improve CV risk stratification in RA patients.

Anti-citrullinated fibrinogen (anti-cit-fibrinogen) may serve as a potential biomarker for assessing cardiovascular (CV) risk in patients with rheumatoid arthritis (RA).

In examining 10 types of anti-cit-fibrinogens in patients with RA, anti-cit-fibrinogens as a group were associated with coronary artery disease (CAD) outcomes, with the association driven by a subset of autoantibodies in a subgroup that contained seven of the 10 anti-cit-fibrinogens, found researchers from Boston and Bordeaux, France.

Boris P. Hejblum, PhD, of Harvard School of Public Health in Boston, and the University of Bordeaux in France, and colleagues wrote that their study supports preclinical data and suggests that anti-cit-fibrinogens can improve CV risk stratification in RA patients.

“While our study adjusted for traditional CV risk factors, future Phase 4 biomarker development studies investigating the predictive value of these biomarkers in an independent cohort are needed,” they wrote in Arthritis Care & Research.

CV disease is the leading cause of death for patients with RA. Traditional risk factors tend to underestimate CV risk in patients with RA. A specific class of anti-citrullinated proteins antibodies (ACPAs), anti-cit-fibrinogen, have been studied as a potential marker for CV disease in RA, with research to suggest “a mechanistic pathway whereby inflammation promoted cit-fibrinogen in atherosclerotic plaques, and thus the development of anti-cit-fibrinogen may be a useful marker of inflammation, atherosclerotic burden and CV risk in RA,” Hejblum and colleagues wrote. A subsequent study that used a different platform to measure anti-cit-fibrinogen, however, failed to detect an association between carotid intima media thickness and anti-cit-fibrinogen titers.

These previous studies examined surrogate CV outcomes, prompting the authors to examine the association between ACPAs and CAD outcomes in a cohort of 1,006 patients with RA from two large tertiary care hospitals. Plasma samples from patients were measured for anti-cit-fibrinogen. Antibodies directed against 10 epitopes of cit-fibrinogen were measured.

The mean age of the patients was 61.0 years; 79.0% were female, and 72.2% were positive for anti-cyclic citrullinated peptide (CCP).

A principal components analysis (PCA) was performed to assess whether the anti-cit-fibrinogens clustered into groups, and each group was tested for its association with CAD.

From the PCA analysis, three main groups emerged: PC1, PC2, and PC3. PC1 accounted for more than 80% of the anti-cit-fibrinogen antibody variability among all anti-cit-fibrinogen antibodies. PC2 explained an additional 7.7% of variability; and PC3, an additional 3.5% of variability.

As a group, the anti-cit-fibrinogens were associated with a higher risk of CAD, adjusted for age, gender, race, diabetes, hypertension, hyperlipidemia, smoking, and use of non-biologic disease-modifying antirheumatic drugs (DMARDs), biologic DMARDs, and prednisone (P=0.00011). By subgroup, the strongest association was observed in group PC2, which included seven of the 10 anti-cit-fibrinogens examined (P=0.015).

A sensitivity analysis using ICD9 codes showed a similar association between anti-cit-fibrinogen as a group with ischemic heart disease (P=0.00029), as well as between-group PC2 and ischemic heart disease (P=0.004). Using the same covariates for adjustment, no association between anti-CCP positivity and CAD was observed (OR 1.3, 95% CI 0.7-2.3).

A total of 897 RA patients had high-sensitivity C-reactive protein (hsCRP) data recorded. The association between anti-cit fibrinogens and CAD remained significant, adjusting for CV risk factors and hsCRP (P=0.00022 among overall cohort, P=0.0071 for group PC2). This association remained significant after adjusting the model to include hsCRP and anti-CCP status. The concentrations of anti-cit fibrinogen therefore provided information additional to anti-CCP in identifying which RA patients had CAD, Hejblum and colleagues said.

They added that the study may explain why some previous reports did not find associations between anti-cit-fibrinogen and surrogate measures of CV risk: “While we detected a significant association between all anti-cit-fibrinogens with CAD, the signal appeared to be driven by a group of targets within the large fibrinogen molecule. Thus, if a particular ACPA assay does not measure antibodies targeting specific regions of fibrinogen, an association with CAD, may not be detected.”

A limitation to the study, the team noted, was the collection of samples in patients with prevalent CAD, thus not permitting an estimation of the value of anti-cit-fibrinogen in predicting future CAD risk.

Funding was provided by the Rheumatology Research Foundation.

  • Reviewed by
    Robert Jasmer, MD Associate Clinical Professor of Medicine, University of California, San Francisco and Dorothy Caputo, MA, BSN, RN, Nurse Planner

1969-12-31T19:00:00-0500

last updated

Tagged with:

About author

Related Articles